Royalty Pharma
Bill Grau currently serves as Vice President at Royalty Pharma since April 2021. Previously, Bill held the position of Associate Vice President in Biotechnology Equity Research at Stifel Financial Corp. from August 2018 to April 2021, along with earlier roles as an Associate and Research Assistant in the same field. Additional experience includes working as an Applications Scientist at Inscripta, Inc., and as an Intern at XSeed Capital. Bill began their career as a Research Assistant at Idaho Bioscience and California Polytechnic State University-San Luis Obispo, and completed an Undergraduate Finance Internship at Amgen. Bill holds a PhD in Organic Chemistry from the University of Colorado Boulder and two Bachelor of Science degrees in Biochemistry and Business Administration (Finance) from California Polytechnic State University-San Luis Obispo.
This person is not in any teams
Royalty Pharma
3 followers
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals, and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies.